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Edited by Vladimir SkulachevAbstract Mitochondrial thioredoxin (mtTrx) can be oxidized in
response to inducers of oxidative stress; yet the functional conse-
quences of the oxidation have not been determined. This study
evaluated the redox status of mtTrx and its association to oxi-
dant-induced apoptosis. Results showed that mtTrx was oxidized
after exposure to peroxides and diamide. Overexpression of
mtTrx protected against diamide-induced oxidation and cytotox-
icity. Oxidation of mtTrx was also achieved by knocking down
its reductase; and lead to increased susceptibility to cell death.
The data indicate that the redox status of mtTrx is a regulatory
mechanism underlying the vulnerability of mitochondria to oxi-
dative injury.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The redox status of protein sulfhydryl groups is essential for
mammalian cell functions [1–3]. Thiol-dependent antioxidant
proteins are key component of the redox regulation system.
They function by eliminating reactive oxygen species (ROS)
and thereby controlling the concentrations of reactive signal-
ing intermediates. Some of these antioxidant proteins, such
as thioredoxin (Trx) and glutaredoxin, also directly reduce
oxidized proteins and reverse the oxidative stress-induced
changes in their activities [4,5].
Trx family proteins are conserved redox proteins containing
the invariant active center -Cys-Gly-Pro-Cys- [6]. Functioning
as electron donors for various redox reactions in vivo, Trxs
play fundamental roles in diverse cellular events by regulating
DNA binding activities of a number of transcription factors as
well as interacting with other protein substrates. Trxs partici-Abbreviations: AMS, 4-acetamido-40-maleimidylstilbene-2,20-disulfonic
acid; mtDw, mitochondrial membrane potential; mtTrx, mitochondrial
thioredoxin; PS, phosphatidylserine; tBH, tert-butylhydroperoxide;
TMRM, tetramethylrhodamine methyl ester; TR, thioredoxin reductase;
Trx1, thioredoxin 1
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ins (Prxs) which detoxify hydrogen peroxide into water. In
mammals there are at least two complete Trx systems, the
cytosolic Trx system (Trx1, thioredoxin reductase 1 (TR1)
and NADPH) and the mitochondrial Trx system (mtTrx, thi-
oredoxin reductase 2 (TR2) and NADPH) [7–10]. The protein
components of these two systems are functional homologues
but are encoded by diﬀerent genes. Both systems are dependent
on NADPH that serves as the ultimate electron donor. Both
Trx1 and mtTrx are capable of reducing insulin in vitro and
are good substrates for either TR1 or TR2 [7–9].
The majority of the functions of Trxs rely on their thiol
reductase activities [6]. In the present study, we showed that,
in response to various conditions of oxidative stress, mtTrx
was more extensively oxidized and slower in recovery than
the cytosolic Trx1. Using overexpression and siRNA
approaches, we showed that the redox status of mtTrx con-
trolled the sensitivity to oxidative stress-induced apoptosis.
Our data suggest that, in addition to the abundant ROS pro-
duction in the mitochondria, the sensitivity of mitochondrial
proteins per se may provide another mechanism that accounts
for the vulnerability of mitochondria to oxidative injury. Oxi-
dation of the mitochondrial protein thiols may lead to in-
creased susceptibility to apoptotic cell death.2. Materials and methods
2.1. Cell culture
Human 143 B osteosarcoma cells were purchased from American
Type Culture Collection (ATCC, Manassas, VA). Cells stably transfec-
ted with full-length human mtTrx were described previously [10].
All cells were cultured in Dulbecco’s modiﬁed Eagle’s medium with
10% fetal bovine serum (FBS) in a humidiﬁed CO2 incubator at
37 C. For all experiments, 80–90% conﬂuent cells were used for treat-
ments.2.2. Protein expression, puriﬁcation and antibody production
The truncated form of human mtTrx that lacks the N-terminal
mitochondrial localization signal [10] was subcloned into pET15b
expression vector (EMD Biosciences, Inc, San Diego, CA) and trans-
formed into Escherichia coli strain BL21 (EMD Biosciences). The
induction and puriﬁcation were performed as described elsewhere with
modiﬁcations [7]. Brieﬂy, the expression of recombinant protein was
induced with 1 mM of isopropyl-beta-D-thiogalactopyranoside at
37 C for 3 h. Cells were harvested by centrifugation at 6000 · g for
10 min and the pellet was resuspended with BugBusterProtein
Extraction Reagent (EMD Biosciences). The lysates were loaded onto
a HiTrap aﬃnity column (Amersham pharmacia Biotech Inc, Piscata-
way, NJ) and the wash and elution steps were performed following the
manufacturer’s instructions. The homogeneity of puriﬁed protein wasblished by Elsevier B.V. All rights reserved.
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into New Zealand White rabbits for the antiserum production (Cov-
ance, Princeton, NJ). The obtained antibody showed speciﬁc binding
to human mtTrx and no cross-reactivity to human Trx1 on Western
blot analyses (data not shown).2.3. Redox Western analysis
To assess the in vivo redox status of mammalian Trxs, we used a
method that was previously described with modiﬁcations [11,12]. The
assay principle is illustrated in Fig. 1. The reduced cysteine residues
were alkylated with 4-acetamido-4 0-maleimidylstilbene-2,2 0-disulfonic
acid (AMS) (Molecular Probes, Eugene, OR) followed by non-reduc-
ing Western blot to distinguish between the reduced (alkylated) and
oxidized (non-alkylated) proteins. Cells were harvested with ice-cold
10% trichloroacetic acid and collected after centrifugation. Pellets were
resuspended with 100% acetone and kept on ice for 15 min. At the end
of incubation, cells were centrifuged for 10 min. The pellet was dis-
solved in lysis buﬀer (62.5 mM Tris–Cl, pH 6.8, 1% SDS) with
25 mM AMS. The lysates were incubated for 30 min at 4 C followed
by 10 min incubation at 37 C. Samples were resolved with 15% non-
reducing SDS–PAGE. Western analysis was performed with antibod-
ies against Trx1 (American Diagnostica, Inc., Greenwich, CT) and
mtTrx. The signals were detected by an Odyssey infrared imaging sys-
tem (LI-COR, Lincoln, NE). The redox status of protein was presented
as the percentage of oxidized proteins.2.4. Knock down TR2 expression by siRNA approach
The siRNA against TR2 (5 0-AAG GAG GAC ACG GGC ACC
U-3 0) was synthesized by Integrated DNA technologies (Coralville,
IA). Control scrambled siRNA was purchased from Ambion (Austin,
TX). Cells were transfected with the double stranded-siRNA using
Lipofectamine 2000 Reagent (Invitrogen). At 36 h after transfec-
tion, cells were further treated with peroxide in fresh media for an
additional 12 h. All treatments were performed in culture media
containing 10% FBS. Cell viability was measured using the LIVE/
DEAD viability/cytotoxicity kit (Molecular Probes) followed by ﬂow
cytometry (BD Immunocytometry Systems, San Jose, CA) as described
[10].2.5. Measurement of mitochondrial depolarization
Diamide (1,1 0-Azobis(N,N-dimethylformamide) was obtained from
Sigma (St. Louis, MO) and was prepared as 1000· stock in water.
Treatments were performed in culture media containing 10% FBS.
Cells were harvested by gentle trypsinization. To measure mitochon-
drial membrane potential (mtDw), cells were stained with 200 nM
tetramethylrhodamine methyl ester (TMRM) in culture media for
15 min at 37 C. After washing with phosphate-buﬀered saline (PBS),
the TMRM ﬂuorescence was analyzed by ﬂow cytometry.Fig. 1. Schematic representation of Redox Western analysis. The
alkylating agent AMS reacts with –SH groups and adds 500 Da in
the molecular weight. The reaction conditions were optimized so that
AMS will not alkylate amines.2.6. Apoptosis assays
Apoptosis was measured by phosphatidylserine (PS) exposure and
caspase activation. After diamide exposure, cells were labeled with
ﬂuorescein-conjugated Annexin V (Molecular Probes) in binding buf-
fer supplied by the manufacturer. The labeling reactions were per-
formed at room temperature for 20 min and the samples were then
kept on ice until analyzed by ﬂow cytometry. To measure caspase
activation, cells were harvested after treatments and incubated with
10 lM FITC-VAD-FMK (Promega, Madison, WI) for 30 min at
37 C. Cells were then washed once with PBS and analyzed by ﬂow
cytometry.3. Results
3.1. Oxidation of Trxs was an early event in oxidative stress
To determine the redox status of mtTrx and Trx1 in vivo, we
used AMS to alkylate thiols of the protein cysteine residues
followed by the Western blot analysis. Alkylation with AMS
adds 500 Da molecular weight to every sulfhydryl group.
When run on non-reducing SDS–PAGE, proteins in their re-
duced (alkylated) and oxidized (non-alkylated) forms can be
resolved by the increase in molecular weight due to the addi-
tion of AMS (Fig. 1).
H2O2 and t-butylhydroperoxide (tBH), a relatively stable
peroxide with potent mitochondrial eﬀects [13], were used to
generate oxidative stress in 143 B human osteosarcoma cells.
The same cell line was used in our previous studies of mtTrx
[10]. Both agents induced oxidation of mtTrx and Trx1 in a
dose-dependent manner (Fig. 2); however, mtTrx and Trx1
showed diﬀerent sensitivities. Treatment with tBH, the perox-
ide inducing mitochondrial oxidative stress [13], induced over
80% oxidation of mtTrx at 50 lM concentration within
10 min. The oxidation is indicated by the appearance of the
faster moving band on the SDS–PAGE (Fig. 2A, labeled as
mtTrx0). The extent of oxidation of mtTrx was not further in-
creased at higher concentrations (Fig. 2B). The maximum oxi-
dation of Trx1 was achieved at 300 lM tBH but was only
40% (Fig. 2B). Similar to mtTrx, oxidized Trx1 moved faster
than its reduced form (Fig. 2A). In contrast to tBH, H2O2 in-
duced maximum oxidation of both mtTrx and Trx1 at concen-
trations over 300 lM (Fig. 2C). Again, mtTrx was oxidized to
a much greater extent.
To study the time course of oxidation of Trxs, the 143 B cells
were treated with 300 lM of either tBH or H2O2, which
induced maximum oxidation of both mtTrx and Trx1, and
monitored for up to 3 h. Both oxidants induced rapid oxida-
tion of mtTrx and Trx1, with the maximal oxidation occurred
within 5 min of treatment (Fig. 3A and B). The response of
Trx1 was found to be transient and lasted for 30 and 60 min,
in cells exposed to H2O2 and tBH, respectively. In contrast,
the majority of mtTrx (70%) remained oxidized at the end
of 3 h incubation with tBH. In H2O2-treated cells, the redox
status of mtTrx returned to base line after 60 min. The diﬀer-
ences in the redox status of mtTrx were associated with diﬀer-
ent extents of mitochondrial damage. Loss of mtDW was
observed in cells treated tBH which induced persistent oxida-
tion; but was not detected in cells exposed to H2O2 which only
induced a transient oxidation of mtTrx (Fig. 3C). During the
incubation time, no signiﬁcant changes in the total protein le-
vel of either Trx1 or mtTrx protein were detected (data not
shown).
To further characterize the responses of mtTrx and Trx1 to
oxidative stress, we treated cells with diamide, a dithiol oxidant
Fig. 2. Dose-dependent changes of the redox status of Trx1 and mtTrx in response to peroxides. (A) The 143 B human osteosarcoma cells were
treated with diﬀerent concentrations of tBH and H2O2 for 10 min. Cells were then harvested and prepared for redox measurement as described in
Section 2. Data presented are representative of three separate experiments. (B) and (C) Quantiﬁcation of the Redox Western data after exposure to
tBH and H2O2, respectively. The redox status of each protein was presented as the percentage of oxidized proteins. The data presented are the
average of three separate experiments (means ± S.E.M.).
Fig. 3. Time courses of peroxide-induced oxidation and mitochondrial
depolarization. Cells were treated with either 300 lM of tBH (A) or
300 lM of H2O2 (B) for the indicated times. The redox status is
presented as the percentage of the oxidized proteins. Results are the
average of four separate experiments (means ± S.E.M.). (C) The mtDw
was measured by TMRM staining and ﬂow cytometry. Time-depen-
dent changes in TMRM ﬂuorescence were shown. Data presented are
the representative of three separate experiments with similar results.
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and protein cysteines [14]. Exposure to diamide resulted in oxi-
dation of mtTrx and Trx1 at comparable level in a dose-depen-
dent manner (Fig. 4A). Both mtTrx and Trx1 reached nearly
complete oxidation within 10 min after treatment with
300 lM diamide. We next examined the time course of oxida-
tion of mtTrx and Trx1 in cells incubated with 300 lM
diamide for up to 4 h (Fig. 4B). Like peroxides, diamide in-
duced a rapid oxidation of both proteins. Unlike peroxides,
the thiol oxidant diamide caused nearly maximal oxidation
of both proteins in 5 min; whereas in peroxides treatment, less
than 50% of Trx1 was oxidized. Gradual reduction to basal
levels of both mtTrx and Trx1 were observed after the maximal
oxidation. MtTrx was slower than Trx1 in recovery (Fig. 4B).
3.2. Overexpression of mtTrx accelerated its recovery from
diamide-induced oxidation and protected cells from the
cytotoxicity
We have shown in our previous studies that overexpression
of mtTrx protected cells from tBH toxicity [10]. To determine
whether similar protection could be achieved against diamide,
we used cells overexpressing mtTrx and treated them with
300 lM diamide. The redox status of mtTrx and Trx1 in vec-
tor- and mtTrx-transfected cells were examined (Fig. 5).
Although the maximum level of oxidized mtTrx was not inﬂu-
enced by overexpression of mtTrx, increased mtTrx facilitated
the recovery of mtTrx from the initial oxidation. After expo-
sure to diamide for 60 min, cells overexpressing mtTrx showed
much lower extent of oxidation of mtTrx (Fig. 5A). No statis-
tically signiﬁcant diﬀerence was observed in redox status of
Trx1 (Fig. 5B).
The time course of mtDw changes were measured in both
vector- and mtTrx-transfected cells after exposure to 300 lM
diamide. Results (Fig. 5C) showed that diamide caused time-
Fig. 5. Overexpression of mtTrx in 143 B cells prevented oxidation of
mtTrx and mitochondrial depolarization induced by diamide. 143 B
cells transfected with empty vector or plasmid expressing mtTrx were
treated with 300 lM diamide for indicated times. Cells were analyzed
with Redox Western analysis to evaluate the redox status of mtTrx (A)
and Trx 1 (B). The data were presented as the averages of ﬁve separate
experiments (means ± S.E.M.). (C) Vector control and mtTrx-over-
expressing cells were treated with 300 lM diamide for indicated time.
MtDw was measured by TMRM staining followed by ﬂow cytometry.
The data presented are the average of ﬁve separate experiments
(means ± S.E.M.). Signiﬁcant diﬀerences from vector-transfected cells,
determined by student’s t-test, are indicated as: *P < 0.05.
Fig. 4. Diamide-induced oxidation of Trx1 and mtTrx in 143 B cells.
Cells were treated with either diﬀerent doses of diamide (A) or 300 lM
diamide for indicated time (B). The redox status of Trx1 and mtTrx
was measured by Western blot analyses. Results are representative of
four separate experiments (means ± S.E.M.).
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as 2 h. Thus, similar to tBH treatment, diamide-induced oxida-
tion of mtTrx was associated with mitochondrial damage.
Overexpression of mtTrx protected cells from loss of mtDw
(Fig. 5C).
Diamide caused dose-dependent cell death in 143 B cells. PS
exposure and caspase activation were measured after cells were
exposed to 300 lM diamide for diﬀerent time. Results showed
that PS exposure (Fig. 6A) and caspase activation (Fig. 6B)
occurred early and both were inhibited by overexpression of
mtTrx. When measured for viability at 16 h, cells treated with
300 lM diamide had only 40% viability (Fig. 6C). Overexpres-
sion of mtTrx rendered cells more resistant to diamide toxicity
at both 300 lM and 400 lM. Because the viability assay was
performed at a relatively late time point as compared to the
caspase activation and mitochondrial depolarization, it is unli-
kely that increased mtTrx only delayed cell death. Thus,
increased mtTrx showed protective eﬀects in both the redox
status of mtTrx and oxidant-induced apoptosis.
3.3. Knockdown of TR2 sensitized cells to oxidant-induced cell
death
Data from our current and previous studies [15,16] indicate
that oxidation of mtTrx is a common consequence to a broad
spectrum of environmental toxicities. In order to further inves-
tigate the functional consequences of the oxidation, we used
siRNA approach to reduce the expression of TR2 in 143B
cells. At 48 h after transfection, the amount of TR2 was
reduced to 52 ± 7% (means ± S.D.) of the control level
(Fig. 7A). TR2 is essential in maintaining mtTrx in its reduced
state via NADPH-dependent redox circuit in the mitochon-
dria. The results suggest that downregulation of TR2 was asso-
ciated with both decreased expression and oxidation of the
mtTrx protein (Fig. 7A and B).
Transfection with siRNA did not induce apparent cytotoxic
eﬀects under the experimental conditions (Fig. 7C). However,when these cells were further exposed to tBH, there was an in-
creased sensitivity to cell death. At 150 lM, tBH induced min-
imal cell death in cells transfected with control scrambled
siRNA, but caused signiﬁcant toxicity in cells transfected with
the siRNA against TR2. Thus, the proper function of the
mtTrx/TR2 system controls the sensitivity to the oxidant-in-
duced cell death in the 143 B cells.4. Discussion
In the present study, we evaluated the oxidative stress-in-
duced changes in the redox status of human mtTrx and
Fig. 6. Protection against diamide-induced apoptosis by overexpressing mtTrx. Cells stably transfected with vector or mtTrx were treated with
300 lM diamide for indicated time. (A) PS exposure was measured by staining with ﬂuorescein-conjugated Annexin V. Data presented are the
representative of two separate experiments. (B) Caspase activation was measured by staining with the ﬂuorogenic substrate FITC-VAD-FMK and
ﬂow cytometry. Data presented are the average of three separate experiments. Signiﬁcant diﬀerences from vector-transfected cells, determined by
student’s t-test, is indicated as: *P < 0.05. (C) Viability was performed after treatment with diamide at indicated concentrations for 16 h, using the
LIVE/DEAD cytotoxicity assay. Duplicate samples were used for each condition. Data presented are the average of three separate experiments
(means ± S.E.M.). Signiﬁcant diﬀerences from vector-transfected cells, determined by student’s t-test, are indicated as **P < 0.01.
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tropic functions but with distinct subcellular localizations.
We demonstrated that both mtTrx and Trx1 were quickly oxi-
dized by peroxides, but to diﬀerent levels. Although mtTrx and
Trx1 belong to the same protein family, contain the conserved
invariable active center, show similar in vitro insulin reduction
activities and function as critical components of local antioxi-
dant networks in individual subcellular compartments [7–9],
they showed diﬀerent sensitivities to oxidative stress. Com-
pared to the cytosolic Trx1, mtTrx was oxidized much more
extensively and persistently (Figs. 2 and 3). Although the ini-
tial oxidation induced by diamide was similar between Trx1
and mtTrx, the latter recovered with a slower rate (Fig. 4). Re-
sults from our current and previous studies [16] indicate that
mtTrx is likely to be one of the mitochondrial proteins, includ-
ing adenine nucleotide translocase [17,18] and aconitase [19],
that are particularly sensitive to oxidative damage.The redox status of Trxs reﬂects the balance between the
local oxidizing power and the reducing capacity of the TRs.
There are two possible mechanisms account for the observed
higher susceptibility of mtTrx to oxidation. First, it may result
from a higher level of local oxidative stress, which is exempli-
ﬁed by the tBH treatment. In cells exposed to tBH, oxidation
of mtTrx lasted much longer than that of Trx1. As demon-
strated by other studies [13], tBH targets mitochondria and
the greater extent of oxidation of mtTrx may be partially
resulted from the local reactive intermediates production.
Alternatively, the disparity between mtTrx and Trx1 may be
caused by a lower activity of the mitochondrial TR system.
Spyrou et al showed that in the presence of TR1, oxidized
Trx1 had lower insulin reduction activity than oxidized mtTrx
[7]. Their data may suggest that mtTrx is less prone to oxida-
tion in vitro. Interestingly, however, data from Rhee’s group
suggested that it may not be the case because TR2 has similar,
Fig. 7. Knockdown TR2 sensitized 143B cells to tBH-induced cell death. Cells transfected with scrambled siRNA or siRNA targeting TR2. (A) The
protein levels of TR2 and mtTrx were measured by Western blot analyses and normalized to b-actin. The ratio between transfection with the
scrambled and the TR2-targeting siRNA was indicated on the bottom. Data presented are the representative of three separate experiments. (B) The
redox status of mtTrx was measured 48 h after transfection with either control scrambled siRNA or TR2-targeting siRNA. Data presented are the
average of three separate experiments (means ± S.E.M.). **P < 0.01, student’s t-test. (C) At 36 h after transfection, cells were exposed to diﬀerent
concentrations of tBH for additional 16 h and measured for viability. The data presented are the averages of three separate experiments
(means ± S.E.M.). *P < 0.05, student’s t-test.
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Despite the controversy, our measurements using intact cells
clearly indicate that mtTrx is more prone to oxidation than
Trx1 after exposure to peroxides and diamide.
Although Trx1 and mtTrx are functional homologues, they
are diﬀerent proteins encoded by diﬀerent genes. There are
potentially various factors that can inﬂuence their redox
status. In diamide treatment (Figs. 4 and 5), the initial oxida-
tion was similar between Trx1 and mtTrx; however, the recov-
ery rate was distinct between the two proteins. The data
suggest that there are diﬀerences in the kinetics and/or the
capability of reducing oxidized mtTrx and Trx1 in diﬀerent
subcellular compartments. Compared to the in vitro reconsti-
tution system, Trxs in vivo are exposed to a more diverse and
dynamic microenvironment and, consequently, interact with a
variety of proteins. The protein interactions will likely inﬂu-
ence the function by which TRs control the redox status of
Trxs.
Although oxidation of mtTrx has been reported, the implica-
tions in the redox regulated functions have not been well char-
acterized. Our data indicate that the initial oxidation of mtTrx
was caused by chemical exposure and may not always be asso-
ciated to perturbation of the cellular function. For instance,
both 50 lM tBH and 100 lM H2O2 caused nearly complete
oxidation of mtTrx (Fig. 2). However, neither condition was
lethal. Cells recovered quickly after the initial exposure. In fact
if the peroxides were removed from the media, the redox status
of mtTrx returned to basal level within minutes (data not
shown). Similar observations were obtained with diamide
treatment, which at 200 lM concentration induced nearly
maximal oxidation of mtTrx (Fig. 4A) but was proved to be
not lethal in the 143B osteosarcoma cells (Fig. 6C).In contrast to the initial reversible oxidation, prolonged oxi-
dation of mtTrx is associated with severe cytotoxicity and cell
death. At 300 lM, tBH induced persistent oxidation of mtTrx
(Fig. 3A), mitochondrial depolarization (Fig. 3C) and cell
death [10]. H2O2 at the same concentration was not lethal
and, accordingly, the oxidation of mtTrx lasted only less than
60 min (Fig. 3B) and was not associated with mitochondrial
damage (Fig. 3C). Diamide at 300 lM also induced oxidation
longer than 2 h (Fig. 5B) and was associated with mitochon-
drial depolarization (Fig. 5C), caspase activation (Fig. 6B)
and cell death (Fig. 6C). Overexpression of mtTrx facilitated
the recovery from oxidation (Fig. 5B) and protected against
the cell death (Fig. 6C). Oxidation and downregulation of
mtTrx by the siRNA approach potentiated the tBH-induced
cell death (Fig. 7C). Taken together, these data indicate that
the persistent oxidation of mtTrx is a sign of mitochondrial
dysfunction. The redox status of mtTrx is a modulatory factor
of sensitivity to oxidant-induced cell death.
Several redox sensitive components of the mitochondrial
pathway of apoptosis have been identiﬁed. ASK-1 was recently
shown to have a mitochondrial localization and may directly
interact with mtTrx [20]. The adenine nucleotide translocator
(ANT) is known to have critical thiols that modulate the per-
meability transition [17]. Whether the eﬀects of mtTrx were
mediated through these proteins or whether other unknown
proteins are involved remain to be determined.
The sensitivity of mtTrx to oxidative stress may have impor-
tant implications in aging and age-related diseases. Oxidative
damages in mitochondria DNA and lipids have been observed
during the aging process [21,22]. In aging tissues, mitochon-
drial protein damage has also been reported, such as aconi-
tase and ANT [23]. Our data suggest that mtTrx is another
6602 Y. Chen et al. / FEBS Letters 580 (2006) 6596–6602important target. Like its cytosolic isoform Trx1, mtTrx is an
essential component of antioxidant systems. An oxidation of
the mtTrx pool may trigger a chain reaction that dramatically
alter the posttranslational modiﬁcations of a variety of mito-
chondrial proteins and lead to catastrophic damages to mito-
chondrial structure and function.
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